Type of publication:
Viljoen A.; Fuat A.; Takhar A.; Williams S.; *Capps N.
Prescriber; Jul 2019; vol. 30 (no. 7); p. 23-26
Dyslipidaemia is a key risk factor for cardiovascular disease, and its identification and treatment is important for both primary and secondary prevention. This article discusses how to screen for dyslipidaemia and optimise lipid-lowering therapy to improve cardiovascular outcomes.
Link to full-text [NHS OpenAthens account required]